epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
Atacicept
atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Brenzavvy

bexagliflozin

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  TAB: 20 mg

diabetes mellitus, type 2

[20 mg PO qam]
Info: do not crush/chew tab; hold tx at least 3 days before surgery/procedure if prolonged fasting

renal dosing

[see below]
eGFR <30: avoid use
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class A or B: no adjustment; Child-Pugh Class C: not defined, caution advised

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@a384ac5
  • hypersensitivity to drug or ingredient
  • pregnancy 2nd trimester
  • pregnancy 3rd trimester
  • breastfeeding
  • eGFR <30
  • diabetic ketoacidosis
  • volume depletion
  • caution: pregnancy 1st trimester
  • caution: elderly patients
  • caution: eGFR <60
  • caution: hepatic impairment, Child-Pugh Class C
  • caution: hypotension
  • caution: ketoacidosis risk
  • caution: pancreatic disorder
  • caution: fasting
  • caution: febrile illness, acute
  • caution: surgery
  • caution: ketogenic diet
  • caution: alcohol abuse
  • caution: genital mycotic infection history
  • caution: uncircumcised penis
  • caution: amputation history
  • caution: PVD
  • caution: neuropathy
  • caution: diabetic foot ulcer

Drug Interactions .

Overview

bexagliflozin

SGLT2 inhibitor

Interaction Characteristics:
  • UGT1A9 substrate
  • antidiabetic agent
  • fluid/electrolyte loss
  • hypotensive effects

Avoid/Use Alternative

  • aldesleukin
  • Brenzavvy (bexagliflozin)
    +
    aldesleukin
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + aldesleukin

    avoid combo: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • bexagliflozin
  • Brenzavvy (bexagliflozin)
    +
    bexagliflozin
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + bexagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • canagliflozin
  • Brenzavvy (bexagliflozin)
    +
    canagliflozin
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + canagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis, syncope), other adverse effects (additive effects, duplicate therapy)

  • dapagliflozin
  • Brenzavvy (bexagliflozin)
    +
    dapagliflozin
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + dapagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • empagliflozin
  • Brenzavvy (bexagliflozin)
    +
    empagliflozin
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + empagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • ertugliflozin
  • Brenzavvy (bexagliflozin)
    +
    ertugliflozin
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + ertugliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

  • lofexidine
  • Brenzavvy (bexagliflozin)
    +
    lofexidine
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + lofexidine

    use alternative or monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sotagliflozin
  • Brenzavvy (bexagliflozin)
    +
    sotagliflozin
    1 interaction

    Avoid/Use Alternative

    bexagliflozin + sotagliflozin

    avoid combo: combo may incr. risk of hypoglycemia, hypotension (including orthostasis), other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

  • acebutolol
  • Brenzavvy (bexagliflozin)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + acebutolol

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • alclometasone topical
  • Brenzavvy (bexagliflozin)
    +
    alclometasone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + alclometasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alfentanil
  • Brenzavvy (bexagliflozin)
    +
    alfentanil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + alfentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • alfuzosin
  • Brenzavvy (bexagliflozin)
    +
    alfuzosin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + alfuzosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • aliskiren
  • Brenzavvy (bexagliflozin)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aliskiren

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aloe
  • Brenzavvy (bexagliflozin)
    +
    aloe
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aloe

    monitor glucose w/ oral aloe: combo may incr. risk of hypoglycemia (additive effects)

  • alpelisib
  • Brenzavvy (bexagliflozin)
    +
    alpelisib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + alpelisib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • alprostadil intracavernous
  • Brenzavvy (bexagliflozin)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + alprostadil intracavernous

    monitor BP: combo may increase risk of hypotension, including orthostasis (additive effects)

  • amantadine
  • Brenzavvy (bexagliflozin)
    +
    amantadine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + amantadine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • amcinonide topical
  • Brenzavvy (bexagliflozin)
    +
    amcinonide topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + amcinonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • amifostine
  • Brenzavvy (bexagliflozin)
    +
    amifostine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + amifostine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • amiloride
  • Brenzavvy (bexagliflozin)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + amiloride

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amitriptyline
  • Brenzavvy (bexagliflozin)
    +
    amitriptyline
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + amitriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amlodipine
  • Brenzavvy (bexagliflozin)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + amlodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • amoxapine
  • Brenzavvy (bexagliflozin)
    +
    amoxapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + amoxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • apomorphine
  • Brenzavvy (bexagliflozin)
    +
    apomorphine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + apomorphine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • apraclonidine ophthalmic
  • Brenzavvy (bexagliflozin)
    +
    apraclonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + apraclonidine ophthalmic

    monitor BP if apraclonidine IOP adjunct use; postop use OK: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aprocitentan
  • Brenzavvy (bexagliflozin)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aprocitentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • aripiprazole bimonthly injection
  • Brenzavvy (bexagliflozin)
    +
    aripiprazole bimonthly injection
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aripiprazole bimonthly injection

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • aripiprazole lauroxil
  • Brenzavvy (bexagliflozin)
    +
    aripiprazole lauroxil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aripiprazole lauroxil

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • aripiprazole monthly injection
  • Brenzavvy (bexagliflozin)
    +
    aripiprazole monthly injection
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aripiprazole monthly injection

    monitor BP, glucose: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • aripiprazole oral
  • Brenzavvy (bexagliflozin)
    +
    aripiprazole oral
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aripiprazole oral

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • arsenic trioxide
  • Brenzavvy (bexagliflozin)
    +
    arsenic trioxide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + arsenic trioxide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • articaine
  • Brenzavvy (bexagliflozin)
    +
    articaine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + articaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • asenapine
  • Brenzavvy (bexagliflozin)
    +
    asenapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + asenapine

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • ashwagandha
  • Brenzavvy (bexagliflozin)
    +
    ashwagandha
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ashwagandha

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • asparaginase
  • Brenzavvy (bexagliflozin)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + asparaginase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • aspirin
  • Brenzavvy (bexagliflozin)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + aspirin

    monitor glucose, especially w/ high-dose aspirin: combo may incr. risk of hypoglycemia (additive effects)

  • atazanavir
  • Brenzavvy (bexagliflozin)
    +
    atazanavir
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + atazanavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • atenolol
  • Brenzavvy (bexagliflozin)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + atenolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • avanafil
  • Brenzavvy (bexagliflozin)
    +
    avanafil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + avanafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • azilsartan medoxomil
  • Brenzavvy (bexagliflozin)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + azilsartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • benazepril
  • Brenzavvy (bexagliflozin)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + benazepril

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • berberine
  • Brenzavvy (bexagliflozin)
    +
    berberine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + berberine

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • betamethasone
  • Brenzavvy (bexagliflozin)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + betamethasone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • betamethasone topical
  • Brenzavvy (bexagliflozin)
    +
    betamethasone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + betamethasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • betaxolol
  • Brenzavvy (bexagliflozin)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + betaxolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • betaxolol ophthalmic
  • Brenzavvy (bexagliflozin)
    +
    betaxolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + betaxolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bethanechol
  • Brenzavvy (bexagliflozin)
    +
    bethanechol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bethanechol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bismuth subsalicylate
  • Brenzavvy (bexagliflozin)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bismuth subsalicylate

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • bisoprolol
  • Brenzavvy (bexagliflozin)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bisoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bortezomib
  • Brenzavvy (bexagliflozin)
    +
    bortezomib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bortezomib

    monitor BP, glucose: combo may incr. risk of severe hypotension, including orthostasis, syncope; may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects; antagonistic effects)

  • brentuximab vedotin
  • Brenzavvy (bexagliflozin)
    +
    brentuximab vedotin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + brentuximab vedotin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • brexpiprazole
  • Brenzavvy (bexagliflozin)
    +
    brexpiprazole
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + brexpiprazole

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • brigatinib
  • Brenzavvy (bexagliflozin)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + brigatinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • brimonidine ophthalmic
  • Brenzavvy (bexagliflozin)
    +
    brimonidine ophthalmic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + brimonidine ophthalmic

    monitor BP if elevated IOP or presbyopia use; OTC ocular redness use OK: combo may increase risk of hypotension, including orthostasis (additive effects)

  • brimonidine topical
  • Brenzavvy (bexagliflozin)
    +
    brimonidine topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + brimonidine topical

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bromocriptine
  • Brenzavvy (bexagliflozin)
    +
    bromocriptine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bromocriptine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • budesonide
  • Brenzavvy (bexagliflozin)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + budesonide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • bumetanide
  • Brenzavvy (bexagliflozin)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bumetanide

    monitor glucose, electrolytes, volume status, renal fxn, BP: combo may incr. risk of electrolyte abnormalities, dehydration, hypovolemia, renal impairment, hypotension (including orthostasis), other adverse effects; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • bupivacaine
  • Brenzavvy (bexagliflozin)
    +
    bupivacaine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bupivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • bupivacaine liposomal
  • Brenzavvy (bexagliflozin)
    +
    bupivacaine liposomal
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + bupivacaine liposomal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • buprenorphine
  • Brenzavvy (bexagliflozin)
    +
    buprenorphine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + buprenorphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • butorphanol
  • Brenzavvy (bexagliflozin)
    +
    butorphanol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + butorphanol

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • cabergoline
  • Brenzavvy (bexagliflozin)
    +
    cabergoline
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + cabergoline

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • calaspargase
  • Brenzavvy (bexagliflozin)
    +
    calaspargase
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + calaspargase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • candesartan cilexetil
  • Brenzavvy (bexagliflozin)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + candesartan cilexetil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cannabis
  • Brenzavvy (bexagliflozin)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + cannabis

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • capivasertib
  • Brenzavvy (bexagliflozin)
    +
    capivasertib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + capivasertib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • captopril
  • Brenzavvy (bexagliflozin)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + captopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • cariprazine
  • Brenzavvy (bexagliflozin)
    +
    cariprazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + cariprazine

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • carteolol ophthalmic
  • Brenzavvy (bexagliflozin)
    +
    carteolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + carteolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • carvedilol
  • Brenzavvy (bexagliflozin)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + carvedilol

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects; antagonistic effects)

  • cassia cinnamon
  • Brenzavvy (bexagliflozin)
    +
    cassia cinnamon
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + cassia cinnamon

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • ceritinib
  • Brenzavvy (bexagliflozin)
    +
    ceritinib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ceritinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • chloroprocaine
  • Brenzavvy (bexagliflozin)
    +
    chloroprocaine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + chloroprocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • chloroquine
  • Brenzavvy (bexagliflozin)
    +
    chloroquine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + chloroquine

    monitor glucose: combo may incr. risk of hypoglycemia, including life-threatening (additive effects)

  • chlorothiazide
  • Brenzavvy (bexagliflozin)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + chlorothiazide

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • chlorpromazine
  • Brenzavvy (bexagliflozin)
    +
    chlorpromazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + chlorpromazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • chlorthalidone
  • Brenzavvy (bexagliflozin)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + chlorthalidone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • chromium
  • Brenzavvy (bexagliflozin)
    +
    chromium
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + chromium

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • cilostazol
  • Brenzavvy (bexagliflozin)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + cilostazol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ciprofloxacin
  • Brenzavvy (bexagliflozin)
    +
    ciprofloxacin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ciprofloxacin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or severe hypoglycemia, including life-threatening (additive effects, antagonistic effects, fluoroquinolones may alter blood glucose)

  • clarithromycin
  • Brenzavvy (bexagliflozin)
    +
    clarithromycin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clarithromycin

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • clevidipine
  • Brenzavvy (bexagliflozin)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clevidipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clobetasol topical
  • Brenzavvy (bexagliflozin)
    +
    clobetasol topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clobetasol topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • clocortolone topical
  • Brenzavvy (bexagliflozin)
    +
    clocortolone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clocortolone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • clofarabine
  • Brenzavvy (bexagliflozin)
    +
    clofarabine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clofarabine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • clomipramine
  • Brenzavvy (bexagliflozin)
    +
    clomipramine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clomipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clonidine
  • Brenzavvy (bexagliflozin)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clonidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • clozapine
  • Brenzavvy (bexagliflozin)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + clozapine

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • codeine
  • Brenzavvy (bexagliflozin)
    +
    codeine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + codeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • coenzyme Q-10
  • Brenzavvy (bexagliflozin)
    +
    coenzyme Q-10
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + coenzyme Q-10

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • copanlisib
  • Brenzavvy (bexagliflozin)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + copanlisib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects, copanlisib may cause infusion-related hyperglycemia)

  • corticotropin
  • Brenzavvy (bexagliflozin)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + corticotropin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • cortisone
  • Brenzavvy (bexagliflozin)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + cortisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dabrafenib
  • Brenzavvy (bexagliflozin)
    +
    dabrafenib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dabrafenib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • danazol
  • Brenzavvy (bexagliflozin)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + danazol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • darunavir
  • Brenzavvy (bexagliflozin)
    +
    darunavir
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + darunavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • decitabine
  • Brenzavvy (bexagliflozin)
    +
    decitabine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + decitabine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • deflazacort
  • Brenzavvy (bexagliflozin)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + deflazacort

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • delafloxacin
  • Brenzavvy (bexagliflozin)
    +
    delafloxacin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + delafloxacin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or severe hypoglycemia, including life-threatening (additive effects, antagonistic effects, fluoroquinolones may alter blood glucose)

  • denileukin diftitox
  • Brenzavvy (bexagliflozin)
    +
    denileukin diftitox
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + denileukin diftitox

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desflurane
  • Brenzavvy (bexagliflozin)
    +
    desflurane
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + desflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desipramine
  • Brenzavvy (bexagliflozin)
    +
    desipramine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + desipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • desogestrel (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    desogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + desogestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • desonide topical
  • Brenzavvy (bexagliflozin)
    +
    desonide topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + desonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • desoximetasone topical
  • Brenzavvy (bexagliflozin)
    +
    desoximetasone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + desoximetasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dexamethasone
  • Brenzavvy (bexagliflozin)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dexamethasone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dexmedetomidine
  • Brenzavvy (bexagliflozin)
    +
    dexmedetomidine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dexmedetomidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • dexmedetomidine injection
  • Brenzavvy (bexagliflozin)
    +
    dexmedetomidine injection
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dexmedetomidine injection

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • diazoxide
  • Brenzavvy (bexagliflozin)
    +
    diazoxide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + diazoxide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dienogest (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    dienogest (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dienogest (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • diflorasone topical
  • Brenzavvy (bexagliflozin)
    +
    diflorasone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + diflorasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • dihydrocodeine
  • Brenzavvy (bexagliflozin)
    +
    dihydrocodeine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dihydrocodeine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • diltiazem
  • Brenzavvy (bexagliflozin)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + diltiazem

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dinutuximab
  • Brenzavvy (bexagliflozin)
    +
    dinutuximab
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dinutuximab

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • dipyridamole
  • Brenzavvy (bexagliflozin)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dipyridamole

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • disopyramide
  • Brenzavvy (bexagliflozin)
    +
    disopyramide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + disopyramide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • doxazosin
  • Brenzavvy (bexagliflozin)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + doxazosin

    monitor BP, especially during doxazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • doxepin
  • Brenzavvy (bexagliflozin)
    +
    doxepin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + doxepin

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • dronabinol
  • Brenzavvy (bexagliflozin)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + dronabinol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • drospirenone (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    drospirenone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + drospirenone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • duloxetine
  • Brenzavvy (bexagliflozin)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + duloxetine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • eleuthero
  • Brenzavvy (bexagliflozin)
    +
    eleuthero
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + eleuthero

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • enalapril
  • Brenzavvy (bexagliflozin)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + enalapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enalaprilat
  • Brenzavvy (bexagliflozin)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + enalaprilat

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • enfortumab vedotin
  • Brenzavvy (bexagliflozin)
    +
    enfortumab vedotin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + enfortumab vedotin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ensartinib
  • Brenzavvy (bexagliflozin)
    +
    ensartinib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ensartinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • entacapone
  • Brenzavvy (bexagliflozin)
    +
    entacapone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + entacapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • entrectinib
  • Brenzavvy (bexagliflozin)
    +
    entrectinib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + entrectinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ephedra
  • Brenzavvy (bexagliflozin)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ephedra

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • epinephrine
  • Brenzavvy (bexagliflozin)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + epinephrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • eplerenone
  • Brenzavvy (bexagliflozin)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + eplerenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • epoprostenol
  • Brenzavvy (bexagliflozin)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + epoprostenol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • esmolol
  • Brenzavvy (bexagliflozin)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + esmolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • estetrol (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + estetrol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estradiol (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + estradiol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estradiol (hormone replacement)
  • Brenzavvy (bexagliflozin)
    +
    estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + estradiol (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estrogens, conjugated (hormone replacement)
  • Brenzavvy (bexagliflozin)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + estrogens, conjugated (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • estrogens, esterified (hormone replacement)
  • Brenzavvy (bexagliflozin)
    +
    estrogens, esterified (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + estrogens, esterified (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ethacrynic acid
  • Brenzavvy (bexagliflozin)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ethacrynic acid

    monitor volume status, BP, renal fxn, electrolytes, glucose: combo may incr. risk of hypovolemia, dehydration, renal impairment, electrolyte abnormalities, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • ethanol (alcoholic beverage)
  • Brenzavvy (bexagliflozin)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ethanol (alcoholic beverage)

    monitor BP, glucose: combo may incr. risk of severe hypotension (including orthostasis), hypoglycemia (additive effects)

  • ethanol injection
  • Brenzavvy (bexagliflozin)
    +
    ethanol injection
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ethanol injection

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • ethinyl estradiol (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ethinyl estradiol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ethinyl estradiol (hormone replacement)
  • Brenzavvy (bexagliflozin)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ethinyl estradiol (hormone replacement)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • ethionamide
  • Brenzavvy (bexagliflozin)
    +
    ethionamide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ethionamide

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • ethynodiol (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    ethynodiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ethynodiol (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • etonogestrel (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    etonogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + etonogestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • etripamil nasal
  • Brenzavvy (bexagliflozin)
    +
    etripamil nasal
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + etripamil nasal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • everolimus
  • Brenzavvy (bexagliflozin)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + everolimus

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • felodipine
  • Brenzavvy (bexagliflozin)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + felodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fenoldopam
  • Brenzavvy (bexagliflozin)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fenoldopam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fentanyl
  • Brenzavvy (bexagliflozin)
    +
    fentanyl
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fentanyl

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • fenugreek
  • Brenzavvy (bexagliflozin)
    +
    fenugreek
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fenugreek

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • ferumoxytol
  • Brenzavvy (bexagliflozin)
    +
    ferumoxytol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ferumoxytol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • fexinidazole
  • Brenzavvy (bexagliflozin)
    +
    fexinidazole
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fexinidazole

    monitor glucose: combo may decr. bexagliflozin levels, efficacy (UGT possibly induced)

  • flaxseed
  • Brenzavvy (bexagliflozin)
    +
    flaxseed
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + flaxseed

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • flibanserin
  • Brenzavvy (bexagliflozin)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + flibanserin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • fludrocortisone
  • Brenzavvy (bexagliflozin)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fludrocortisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluocinolone otic
  • Brenzavvy (bexagliflozin)
    +
    fluocinolone otic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fluocinolone otic

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluocinolone topical
  • Brenzavvy (bexagliflozin)
    +
    fluocinolone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fluocinolone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluocinonide topical
  • Brenzavvy (bexagliflozin)
    +
    fluocinonide topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fluocinonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluoxetine
  • Brenzavvy (bexagliflozin)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fluoxetine

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • fluphenazine
  • Brenzavvy (bexagliflozin)
    +
    fluphenazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fluphenazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • flurandrenolide topical
  • Brenzavvy (bexagliflozin)
    +
    flurandrenolide topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + flurandrenolide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fluticasone propionate topical
  • Brenzavvy (bexagliflozin)
    +
    fluticasone propionate topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fluticasone propionate topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fosamprenavir
  • Brenzavvy (bexagliflozin)
    +
    fosamprenavir
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fosamprenavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • fosinopril
  • Brenzavvy (bexagliflozin)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fosinopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • foslevodopa
  • Brenzavvy (bexagliflozin)
    +
    foslevodopa
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + foslevodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • fosphenytoin
  • Brenzavvy (bexagliflozin)
    +
    fosphenytoin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + fosphenytoin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • furosemide
  • Brenzavvy (bexagliflozin)
    +
    furosemide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + furosemide

    monitor volume status, BP, renal fxn, electrolytes, glucose: combo may incr. risk of hypovolemia, dehydration, renal impairment, electrolyte abnormalities, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • garlic
  • Brenzavvy (bexagliflozin)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + garlic

    monitor glucose, BP w/ supplemental garlic; dietary intake OK: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • gilteritinib
  • Brenzavvy (bexagliflozin)
    +
    gilteritinib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + gilteritinib

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ginkgo
  • Brenzavvy (bexagliflozin)
    +
    ginkgo
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ginkgo

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • ginseng, American
  • Brenzavvy (bexagliflozin)
    +
    ginseng, American
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ginseng, American

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • ginseng, Asian
  • Brenzavvy (bexagliflozin)
    +
    ginseng, Asian
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ginseng, Asian

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • glimepiride
  • Brenzavvy (bexagliflozin)
    +
    glimepiride
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + glimepiride

    monitor glucose; consider decr. glimepiride dose: combo may incr. risk of hypoglycemia (additive effects)

  • glipizide
  • Brenzavvy (bexagliflozin)
    +
    glipizide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + glipizide

    monitor glucose; consider decr. glipizide dose: combo may incr. risk of hypoglycemia (additive effects)

  • glyburide
  • Brenzavvy (bexagliflozin)
    +
    glyburide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + glyburide

    monitor glucose; consider decr. glyburide dose: combo may incr. risk of hypoglycemia (additive effects)

  • goserelin
  • Brenzavvy (bexagliflozin)
    +
    goserelin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + goserelin

    monitor glucose if prostate cancer use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • guanfacine
  • Brenzavvy (bexagliflozin)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + guanfacine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • gymnema
  • Brenzavvy (bexagliflozin)
    +
    gymnema
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + gymnema

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • halcinonide topical
  • Brenzavvy (bexagliflozin)
    +
    halcinonide topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + halcinonide topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • halobetasol topical
  • Brenzavvy (bexagliflozin)
    +
    halobetasol topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + halobetasol topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • haloperidol
  • Brenzavvy (bexagliflozin)
    +
    haloperidol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + haloperidol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydralazine
  • Brenzavvy (bexagliflozin)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + hydralazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • hydrochlorothiazide
  • Brenzavvy (bexagliflozin)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + hydrochlorothiazide

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • hydrocodone
  • Brenzavvy (bexagliflozin)
    +
    hydrocodone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + hydrocodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydrocortisone
  • Brenzavvy (bexagliflozin)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + hydrocortisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • hydrocortisone topical
  • Brenzavvy (bexagliflozin)
    +
    hydrocortisone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + hydrocortisone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • hydromorphone
  • Brenzavvy (bexagliflozin)
    +
    hydromorphone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + hydromorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • hydroxychloroquine
  • Brenzavvy (bexagliflozin)
    +
    hydroxychloroquine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + hydroxychloroquine

    monitor glucose: combo may incr. risk of hypoglycemia, including life-threatening (additive effects)

  • iloperidone
  • Brenzavvy (bexagliflozin)
    +
    iloperidone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + iloperidone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • iloprost
  • Brenzavvy (bexagliflozin)
    +
    iloprost
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + iloprost

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • imipramine
  • Brenzavvy (bexagliflozin)
    +
    imipramine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + imipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • inavolisib
  • Brenzavvy (bexagliflozin)
    +
    inavolisib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + inavolisib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • indapamide
  • Brenzavvy (bexagliflozin)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + indapamide

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • insulin
  • Brenzavvy (bexagliflozin)
    +
    insulin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + insulin

    monitor glucose; consider dose adjustment of one or both drugs: combo may incr. risk of hypoglycemia (additive effects)

  • irbesartan
  • Brenzavvy (bexagliflozin)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + irbesartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • iron sucrose
  • Brenzavvy (bexagliflozin)
    +
    iron sucrose
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + iron sucrose

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isocarboxazid
  • Brenzavvy (bexagliflozin)
    +
    isocarboxazid
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + isocarboxazid

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • isoflurane
  • Brenzavvy (bexagliflozin)
    +
    isoflurane
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + isoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • isoniazid
  • Brenzavvy (bexagliflozin)
    +
    isoniazid
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + isoniazid

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • isosorbide dinitrate
  • Brenzavvy (bexagliflozin)
    +
    isosorbide dinitrate
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + isosorbide dinitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isosorbide mononitrate
  • Brenzavvy (bexagliflozin)
    +
    isosorbide mononitrate
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + isosorbide mononitrate

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • isradipine
  • Brenzavvy (bexagliflozin)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + isradipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • labetalol
  • Brenzavvy (bexagliflozin)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + labetalol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • landiolol
  • Brenzavvy (bexagliflozin)
    +
    landiolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + landiolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • lanreotide
  • Brenzavvy (bexagliflozin)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lanreotide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • leuprolide
  • Brenzavvy (bexagliflozin)
    +
    leuprolide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + leuprolide

    monitor glucose if prostate cancer use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • levobunolol ophthalmic
  • Brenzavvy (bexagliflozin)
    +
    levobunolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + levobunolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • levodopa
  • Brenzavvy (bexagliflozin)
    +
    levodopa
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + levodopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • levofloxacin
  • Brenzavvy (bexagliflozin)
    +
    levofloxacin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + levofloxacin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or severe hypoglycemia, including life-threatening (additive effects, antagonistic effects, fluoroquinolones may alter blood glucose)

  • levonorgestrel (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + levonorgestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • levorphanol
  • Brenzavvy (bexagliflozin)
    +
    levorphanol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + levorphanol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • levothyroxine
  • Brenzavvy (bexagliflozin)
    +
    levothyroxine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + levothyroxine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lidocaine
  • Brenzavvy (bexagliflozin)
    +
    lidocaine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lidocaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • linezolid
  • Brenzavvy (bexagliflozin)
    +
    linezolid
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + linezolid

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • liothyronine
  • Brenzavvy (bexagliflozin)
    +
    liothyronine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + liothyronine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lisinopril
  • Brenzavvy (bexagliflozin)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lisinopril

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • lithium
  • Brenzavvy (bexagliflozin)
    +
    lithium
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lithium

    monitor lithium levels: combo may decr. lithium levels, efficacy (mechanism unknown)

  • lopinavir/ritonavir
  • Brenzavvy (bexagliflozin)
    +
    lopinavir/ ritonavir
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lopinavir/ ritonavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • lorlatinib
  • Brenzavvy (bexagliflozin)
    +
    lorlatinib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lorlatinib

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • losartan
  • Brenzavvy (bexagliflozin)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + losartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • loxapine
  • Brenzavvy (bexagliflozin)
    +
    loxapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + loxapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lubiprostone
  • Brenzavvy (bexagliflozin)
    +
    lubiprostone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lubiprostone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • lumateperone
  • Brenzavvy (bexagliflozin)
    +
    lumateperone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lumateperone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • lurasidone
  • Brenzavvy (bexagliflozin)
    +
    lurasidone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lurasidone

    monitor glucose, BP; consider lowest lurasidone start dose, titrate slowly: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • lutetium Lu 177 dotatate
  • Brenzavvy (bexagliflozin)
    +
    lutetium Lu 177 dotatate
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + lutetium Lu 177 dotatate

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • magnesium sulfate
  • Brenzavvy (bexagliflozin)
    +
    magnesium sulfate
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + magnesium sulfate

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • maraviroc
  • Brenzavvy (bexagliflozin)
    +
    maraviroc
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + maraviroc

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mecasermin
  • Brenzavvy (bexagliflozin)
    +
    mecasermin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + mecasermin

    monitor glucose: combo may incr. risk of severe hypoglycemia (additive effects)

  • medroxyprogesterone (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + medroxyprogesterone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • megestrol
  • Brenzavvy (bexagliflozin)
    +
    megestrol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + megestrol

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • meperidine
  • Brenzavvy (bexagliflozin)
    +
    meperidine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + meperidine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • mepivacaine
  • Brenzavvy (bexagliflozin)
    +
    mepivacaine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + mepivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methadone
  • Brenzavvy (bexagliflozin)
    +
    methadone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + methadone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • methohexital
  • Brenzavvy (bexagliflozin)
    +
    methohexital
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + methohexital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methyldopa
  • Brenzavvy (bexagliflozin)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + methyldopa

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylene blue injection
  • Brenzavvy (bexagliflozin)
    +
    methylene blue injection
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + methylene blue injection

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • methylprednisolone
  • Brenzavvy (bexagliflozin)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + methylprednisolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • methyltestosterone
  • Brenzavvy (bexagliflozin)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + methyltestosterone

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • metolazone
  • Brenzavvy (bexagliflozin)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + metolazone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • metoprolol
  • Brenzavvy (bexagliflozin)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + metoprolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • metreleptin
  • Brenzavvy (bexagliflozin)
    +
    metreleptin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + metreleptin

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • midazolam
  • Brenzavvy (bexagliflozin)
    +
    midazolam
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + midazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • milk thistle
  • Brenzavvy (bexagliflozin)
    +
    milk thistle
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + milk thistle

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • milrinone
  • Brenzavvy (bexagliflozin)
    +
    milrinone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + milrinone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • milsaperidone
  • Brenzavvy (bexagliflozin)
    +
    milsaperidone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + milsaperidone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • minoxidil
  • Brenzavvy (bexagliflozin)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + minoxidil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mirtazapine
  • Brenzavvy (bexagliflozin)
    +
    mirtazapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + mirtazapine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • moexipril
  • Brenzavvy (bexagliflozin)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + moexipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • molindone
  • Brenzavvy (bexagliflozin)
    +
    molindone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + molindone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • mometasone topical
  • Brenzavvy (bexagliflozin)
    +
    mometasone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + mometasone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • morphine
  • Brenzavvy (bexagliflozin)
    +
    morphine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + morphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • moxifloxacin
  • Brenzavvy (bexagliflozin)
    +
    moxifloxacin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + moxifloxacin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or severe hypoglycemia, including life-threatening (additive effects, antagonistic effects, fluoroquinolones may alter blood glucose)

  • nadolol
  • Brenzavvy (bexagliflozin)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nadolol

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects; antagonistic effects)

  • nalbuphine
  • Brenzavvy (bexagliflozin)
    +
    nalbuphine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nalbuphine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nateglinide
  • Brenzavvy (bexagliflozin)
    +
    nateglinide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nateglinide

    monitor glucose; consider decr. nateglinide dose: combo may incr. risk of hypoglycemia (additive effects)

  • nattokinase
  • Brenzavvy (bexagliflozin)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nattokinase

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • naxitamab
  • Brenzavvy (bexagliflozin)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + naxitamab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nebivolol
  • Brenzavvy (bexagliflozin)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nebivolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nelfinavir
  • Brenzavvy (bexagliflozin)
    +
    nelfinavir
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nelfinavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nevirapine
  • Brenzavvy (bexagliflozin)
    +
    nevirapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nevirapine

    monitor glucose: combo may decr. bexagliflozin levels, efficacy (UGT induced)

  • niacin (vitamin B3)
  • Brenzavvy (bexagliflozin)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + niacin (vitamin B3)

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • nicardipine
  • Brenzavvy (bexagliflozin)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nicardipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nifedipine
  • Brenzavvy (bexagliflozin)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nifedipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nimodipine
  • Brenzavvy (bexagliflozin)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nimodipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nisoldipine
  • Brenzavvy (bexagliflozin)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nisoldipine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitric oxide
  • Brenzavvy (bexagliflozin)
    +
    nitric oxide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nitric oxide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • nitrite
  • Brenzavvy (bexagliflozin)
    +
    nitrite
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nitrite

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis, syncope (additive effects)

  • nitroglycerin
  • Brenzavvy (bexagliflozin)
    +
    nitroglycerin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nitroglycerin

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • nitroprusside
  • Brenzavvy (bexagliflozin)
    +
    nitroprusside
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nitroprusside

    monitor BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis (additive effects)

  • norelgestromin (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    norelgestromin (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + norelgestromin (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norepinephrine
  • Brenzavvy (bexagliflozin)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + norepinephrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norethindrone (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    norethindrone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + norethindrone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norgestimate (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    norgestimate (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + norgestimate (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • norgestrel (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    norgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + norgestrel (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • nortriptyline
  • Brenzavvy (bexagliflozin)
    +
    nortriptyline
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + nortriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • obinutuzumab
  • Brenzavvy (bexagliflozin)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + obinutuzumab

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • octreotide
  • Brenzavvy (bexagliflozin)
    +
    octreotide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + octreotide

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • ofloxacin
  • Brenzavvy (bexagliflozin)
    +
    ofloxacin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ofloxacin

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or severe hypoglycemia, including life-threatening (additive effects, antagonistic effects, fluoroquinolones may alter blood glucose)

  • olanzapine
  • Brenzavvy (bexagliflozin)
    +
    olanzapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + olanzapine

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • oliceridine
  • Brenzavvy (bexagliflozin)
    +
    oliceridine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + oliceridine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • olmesartan medoxomil
  • Brenzavvy (bexagliflozin)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + olmesartan medoxomil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • opicapone
  • Brenzavvy (bexagliflozin)
    +
    opicapone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + opicapone

    monitor BP; consider decr. dose of one or both drugs: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • opium
  • Brenzavvy (bexagliflozin)
    +
    opium
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + opium

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxazepam
  • Brenzavvy (bexagliflozin)
    +
    oxazepam
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + oxazepam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • oxycodone
  • Brenzavvy (bexagliflozin)
    +
    oxycodone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + oxycodone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • oxymorphone
  • Brenzavvy (bexagliflozin)
    +
    oxymorphone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + oxymorphone

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • paliperidone
  • Brenzavvy (bexagliflozin)
    +
    paliperidone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + paliperidone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • palopegteriparatide
  • Brenzavvy (bexagliflozin)
    +
    palopegteriparatide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + palopegteriparatide

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • paltusotine
  • Brenzavvy (bexagliflozin)
    +
    paltusotine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + paltusotine

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • pasireotide
  • Brenzavvy (bexagliflozin)
    +
    pasireotide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pasireotide

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pegaspargase
  • Brenzavvy (bexagliflozin)
    +
    pegaspargase
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pegaspargase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • peginterferon alfa 2a
  • Brenzavvy (bexagliflozin)
    +
    peginterferon alfa 2a
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + peginterferon alfa 2a

    monitor glucose: combo may alter glycemic control, incr. risk of hyperglycemia or hypoglycemia (additive effects, antagonistic effects)

  • pegvisomant
  • Brenzavvy (bexagliflozin)
    +
    pegvisomant
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pegvisomant

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • pentamidine
  • Brenzavvy (bexagliflozin)
    +
    pentamidine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pentamidine

    monitor glucose, BP: combo may incr. risk of severe or life-threatening hypotension, including orthostasis; may alter glycemic control, incr. risk of hyperglycemia or severe or life-threatening hypoglycemia (additive effects, antagonistic effects)

  • pentazocine
  • Brenzavvy (bexagliflozin)
    +
    pentazocine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pentazocine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • pentobarbital
  • Brenzavvy (bexagliflozin)
    +
    pentobarbital
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pentobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • perindopril
  • Brenzavvy (bexagliflozin)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + perindopril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • perphenazine
  • Brenzavvy (bexagliflozin)
    +
    perphenazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + perphenazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • phenelzine
  • Brenzavvy (bexagliflozin)
    +
    phenelzine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + phenelzine

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • phenobarbital
  • Brenzavvy (bexagliflozin)
    +
    phenobarbital
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + phenobarbital

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenoxybenzamine
  • Brenzavvy (bexagliflozin)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + phenoxybenzamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phentolamine
  • Brenzavvy (bexagliflozin)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + phentolamine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • phenylephrine
  • Brenzavvy (bexagliflozin)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + phenylephrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • phenytoin
  • Brenzavvy (bexagliflozin)
    +
    phenytoin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + phenytoin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pindolol
  • Brenzavvy (bexagliflozin)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pindolol

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • plozasiran
  • Brenzavvy (bexagliflozin)
    +
    plozasiran
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + plozasiran

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • pramipexole
  • Brenzavvy (bexagliflozin)
    +
    pramipexole
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pramipexole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prazosin
  • Brenzavvy (bexagliflozin)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + prazosin

    monitor BP, especially during prazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • prednicarbate topical
  • Brenzavvy (bexagliflozin)
    +
    prednicarbate topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + prednicarbate topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prednisolone
  • Brenzavvy (bexagliflozin)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + prednisolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • prednisone
  • Brenzavvy (bexagliflozin)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + prednisone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • procarbazine
  • Brenzavvy (bexagliflozin)
    +
    procarbazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + procarbazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • prochlorperazine
  • Brenzavvy (bexagliflozin)
    +
    prochlorperazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + prochlorperazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • promethazine
  • Brenzavvy (bexagliflozin)
    +
    promethazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + promethazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propafenone
  • Brenzavvy (bexagliflozin)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + propafenone

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • propofol
  • Brenzavvy (bexagliflozin)
    +
    propofol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + propofol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • propranolol
  • Brenzavvy (bexagliflozin)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + propranolol

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • protriptyline
  • Brenzavvy (bexagliflozin)
    +
    protriptyline
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + protriptyline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • pseudoephedrine
  • Brenzavvy (bexagliflozin)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + pseudoephedrine

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • quetiapine
  • Brenzavvy (bexagliflozin)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + quetiapine

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • quinapril
  • Brenzavvy (bexagliflozin)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + quinapril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • quinine
  • Brenzavvy (bexagliflozin)
    +
    quinine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + quinine

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • ramipril
  • Brenzavvy (bexagliflozin)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ramipril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rasagiline
  • Brenzavvy (bexagliflozin)
    +
    rasagiline
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + rasagiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • remifentanil
  • Brenzavvy (bexagliflozin)
    +
    remifentanil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + remifentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • remimazolam
  • Brenzavvy (bexagliflozin)
    +
    remimazolam
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + remimazolam

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • repaglinide
  • Brenzavvy (bexagliflozin)
    +
    repaglinide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + repaglinide

    monitor glucose; consider decr. repaglinide dose: combo may incr. risk of hypoglycemia (additive effects)

  • ribose
  • Brenzavvy (bexagliflozin)
    +
    ribose
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ribose

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • rifampin
  • Brenzavvy (bexagliflozin)
    +
    rifampin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + rifampin

    monitor glucose: combo may decr. bexagliflozin levels, efficacy (UGT induced)

  • riociguat
  • Brenzavvy (bexagliflozin)
    +
    riociguat
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + riociguat

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • risperidone
  • Brenzavvy (bexagliflozin)
    +
    risperidone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + risperidone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • ritonavir
  • Brenzavvy (bexagliflozin)
    +
    ritonavir
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ritonavir

    monitor glucose: combo may decr. bexagliflozin levels, antidiabetic agent efficacy (UGT induced, antagonistic effects)

  • ropinirole
  • Brenzavvy (bexagliflozin)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ropinirole

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • ropivacaine
  • Brenzavvy (bexagliflozin)
    +
    ropivacaine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ropivacaine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • rotigotine transdermal
  • Brenzavvy (bexagliflozin)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + rotigotine transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sacrosidase
  • Brenzavvy (bexagliflozin)
    +
    sacrosidase
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sacrosidase

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sacubitril
  • Brenzavvy (bexagliflozin)
    +
    sacubitril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sacubitril

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • safinamide
  • Brenzavvy (bexagliflozin)
    +
    safinamide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + safinamide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • segesterone (contraceptive)
  • Brenzavvy (bexagliflozin)
    +
    segesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + segesterone (contraceptive)

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • selegiline
  • Brenzavvy (bexagliflozin)
    +
    selegiline
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + selegiline

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • selegiline transdermal
  • Brenzavvy (bexagliflozin)
    +
    selegiline transdermal
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + selegiline transdermal

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sevoflurane
  • Brenzavvy (bexagliflozin)
    +
    sevoflurane
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sevoflurane

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • sildenafil
  • Brenzavvy (bexagliflozin)
    +
    sildenafil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sildenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • silodosin
  • Brenzavvy (bexagliflozin)
    +
    silodosin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + silodosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • sirolimus albumin-bound
  • Brenzavvy (bexagliflozin)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sirolimus albumin-bound

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sodium ferric gluconate complex
  • Brenzavvy (bexagliflozin)
    +
    sodium ferric gluconate complex
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sodium ferric gluconate complex

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • somapacitan
  • Brenzavvy (bexagliflozin)
    +
    somapacitan
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + somapacitan

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • somatrogon
  • Brenzavvy (bexagliflozin)
    +
    somatrogon
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + somatrogon

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • somatropin
  • Brenzavvy (bexagliflozin)
    +
    somatropin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + somatropin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • sotalol
  • Brenzavvy (bexagliflozin)
    +
    sotalol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sotalol

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • sparsentan
  • Brenzavvy (bexagliflozin)
    +
    sparsentan
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sparsentan

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • spironolactone
  • Brenzavvy (bexagliflozin)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + spironolactone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • sucralfate
  • Brenzavvy (bexagliflozin)
    +
    sucralfate
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sucralfate

    monitor glucose w/ sucralfate oral suspension: combo may decr. antidiabetic agent efficacy (antagonistic effects, oral suspension contains sorbitol)

  • sufentanil
  • Brenzavvy (bexagliflozin)
    +
    sufentanil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sufentanil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • sunitinib
  • Brenzavvy (bexagliflozin)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + sunitinib

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • tadalafil
  • Brenzavvy (bexagliflozin)
    +
    tadalafil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tadalafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tagraxofusp
  • Brenzavvy (bexagliflozin)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tagraxofusp

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tamsulosin
  • Brenzavvy (bexagliflozin)
    +
    tamsulosin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tamsulosin

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tapentadol
  • Brenzavvy (bexagliflozin)
    +
    tapentadol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tapentadol

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • taurine
  • Brenzavvy (bexagliflozin)
    +
    taurine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + taurine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • telmisartan
  • Brenzavvy (bexagliflozin)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + telmisartan

    monitor glucose, BP: combo may decr. bexagliflozin levels, efficacy; may incr. risk of hypotension, including orthostasis (UGT induced; additive effects)

  • temsirolimus
  • Brenzavvy (bexagliflozin)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + temsirolimus

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • teprotumumab
  • Brenzavvy (bexagliflozin)
    +
    teprotumumab
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + teprotumumab

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • terazosin
  • Brenzavvy (bexagliflozin)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + terazosin

    monitor BP, especially during terazosin initiation/titration: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tesamorelin
  • Brenzavvy (bexagliflozin)
    +
    tesamorelin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tesamorelin

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • testosterone
  • Brenzavvy (bexagliflozin)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + testosterone

    monitor glucose: combo may incr. risk of hypoglycemia (additive effects)

  • thalidomide
  • Brenzavvy (bexagliflozin)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + thalidomide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thioridazine
  • Brenzavvy (bexagliflozin)
    +
    thioridazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + thioridazine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • thiothixene
  • Brenzavvy (bexagliflozin)
    +
    thiothixene
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + thiothixene

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • thyroid
  • Brenzavvy (bexagliflozin)
    +
    thyroid
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + thyroid

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • timolol
  • Brenzavvy (bexagliflozin)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + timolol

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • timolol ophthalmic
  • Brenzavvy (bexagliflozin)
    +
    timolol ophthalmic
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + timolol ophthalmic

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • tipranavir
  • Brenzavvy (bexagliflozin)
    +
    tipranavir
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tipranavir

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • tizanidine
  • Brenzavvy (bexagliflozin)
    +
    tizanidine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tizanidine

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • tolcapone
  • Brenzavvy (bexagliflozin)
    +
    tolcapone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tolcapone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • torsemide
  • Brenzavvy (bexagliflozin)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + torsemide

    monitor volume status, BP, renal fxn, electrolytes, glucose: combo may incr. risk of hypovolemia, dehydration, renal impairment, electrolyte abnormalities, hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • tramadol
  • Brenzavvy (bexagliflozin)
    +
    tramadol
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tramadol

    monitor glucose, BP: combo may incr. risk of severe hypoglycemia, severe hypotension, including orthostasis, syncope (additive effects)

  • trandolapril
  • Brenzavvy (bexagliflozin)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + trandolapril

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • tranylcypromine
  • Brenzavvy (bexagliflozin)
    +
    tranylcypromine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + tranylcypromine

    monitor glucose, BP: combo may incr. risk of hypoglycemia, hypotension, including orthostasis (additive effects)

  • trazodone
  • Brenzavvy (bexagliflozin)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + trazodone

    monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

  • treprostinil
  • Brenzavvy (bexagliflozin)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + treprostinil

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis, syncope (additive effects)

  • triamcinolone
  • Brenzavvy (bexagliflozin)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + triamcinolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • triamcinolone topical
  • Brenzavvy (bexagliflozin)
    +
    triamcinolone topical
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + triamcinolone topical

    monitor glucose w/ prolonged topical corticosteroid use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • triamterene
  • Brenzavvy (bexagliflozin)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + triamterene

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

  • trifluoperazine
  • Brenzavvy (bexagliflozin)
    +
    trifluoperazine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + trifluoperazine

    monitor BP: combo may incr. risk of severe hypotension, including orthostasis (additive effects)

  • trimipramine
  • Brenzavvy (bexagliflozin)
    +
    trimipramine
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + trimipramine

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • triptorelin
  • Brenzavvy (bexagliflozin)
    +
    triptorelin
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + triptorelin

    monitor glucose if prostate cancer use: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • turmeric
  • Brenzavvy (bexagliflozin)
    +
    turmeric
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + turmeric

    monitor glucose w/ oral turmeric: combo may incr. risk of hypoglycemia (additive effects)

  • valsartan
  • Brenzavvy (bexagliflozin)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + valsartan

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vamorolone
  • Brenzavvy (bexagliflozin)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + vamorolone

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • vardenafil
  • Brenzavvy (bexagliflozin)
    +
    vardenafil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + vardenafil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • verapamil
  • Brenzavvy (bexagliflozin)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + verapamil

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • vorinostat
  • Brenzavvy (bexagliflozin)
    +
    vorinostat
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + vorinostat

    monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

  • vosoritide
  • Brenzavvy (bexagliflozin)
    +
    vosoritide
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + vosoritide

    monitor BP: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • yohimbe
  • Brenzavvy (bexagliflozin)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + yohimbe

    monitor BP, especially w/ high yohimbe doses: combo may incr. risk of hypotension, including orthostasis (additive effects)

  • ziprasidone
  • Brenzavvy (bexagliflozin)
    +
    ziprasidone
    1 interaction

    Monitor/Modify Tx

    bexagliflozin + ziprasidone

    monitor glucose, BP: combo may incr. risk of hypotension, including orthostasis, syncope; may decr. antidiabetic agent efficacy (additive effects; antagonistic effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@6be707e1
  • hypersensitivity reaction
  • anaphylaxis
  • acute kidney injury
  • hypotension
  • ketoacidosis
  • UTI, serious
  • sepsis
  • fractures
  • lower limb amputation risk
  • Fournier gangrene

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@4748f34c
  • volume depletion
  • urination incr.
  • UTI
  • genital mycotic infection
  • rash
  • thirst
  • vulvovaginal pruritus
  • lower limb amputation risk
  • Cr incr.
  • LDL-C incr.
  • Hgb incr.

Safety/Monitoring .

Monitoring Parameters
Cr at baseline, then periodically; BP; consider urine ketones if ketoacidosis risk

Pregnancy/Lactation .

Pregnancy

Clinical Summary

avoid use in 2nd and 3rd trimester, weigh risk/benefit in 1st trimester; no human data available; possible risk of irreversible adverse effects on renal development and maturation in 2nd and 3rd trimesters based on animal data at 11x recommended human dose and drug's mechanism of action; no known risk of teratogenicity in 1st trimester based on animal data at 551x recommended human dose

Lactation

Clinical Summary

avoid use while breastfeeding; no human data available, though possible risk of adverse effects on infant renal development and maturation based on drug's mechanism of action; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@5a59c2fc

Metabolism: for bexagliflozin: liver; CYP450: 3A4 substrate; UGT: 1A9 (primary) substrate

Excretion: for bexagliflozin: feces 51% (29% unchanged), uring 41% (2% unchanged); Half-life: 12h

Subclass: Diabetes: SGLT2 Inhibitors

Mechanism of Action
for bexagliflozin: inhibits sodium-glucose cotransporter 2 (SGLT2), reducing glucose/sodium reabsorption, incr. urinary glucose excretion and sodium delivery to distal tubule

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: TheracosBio, LLC

com.epocrates.rxweb.beans.DrugOtherInfoBean@641d56ed

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information